Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.
Division of Cardiology, Central Arkansas Veterans Health System, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Catheter Cardiovasc Interv. 2019 Jan 1;93(1):E24-E29. doi: 10.1002/ccd.27869. Epub 2018 Oct 22.
The intraplaque injection of contrast media in the recanalization of coronary chronic total occlusions (CTO) has witnessed a dynamic journey since its initial formulation. Contrast-guided subintimal tracking and re-entry (STAR) was the first contrast modulation technique for CTO percutaneous coronary intervention (PCI). With this technique, a forceful injection of a large volume of contrast (3-4 mL) was performed in order to achieve hydraulic recanalization of the vessel. This approach was associated with extensive vessel injury and unpredictable true lumen re-entry, which were in turn linked to high rates of restenosis on follow-up. In the subsequent iteration, called the "microchannel technique", a smaller amount of contrast media (1 mL) was gently injected inside the plaque to modify its compliance by softening and recruiting loose tissue, which facilitated subsequent true-to-true lumen crossing with a polymer-jacketed wire along paths of least resistance. The microchannel technique has later evolved into what is currently known as the "Carlino technique", where a minimal volume of contrast media (<0.5 mL) is gently injected inside the occlusion, with the goal of modifying plaque compliance to facilitate guidewire and microcatheter advancement through a fibrocalcific plaque. The Carlino technique is now widely utilized to allow negotiation of difficult-to-cross occlusions, particularly by the "hybrid operators", with high success rates and low incidence of complications. The purpose of this article is to provide a historical perspective on the use of contrast modulation in CTO PCI, its pathophysiological basis, as well as technical recommendations on how and when to perform these maneuvers.
斑块内注射对比剂在冠状动脉慢性完全闭塞(CTO)再通中的应用经历了一个动态的发展过程。对比剂引导的内膜下跟踪和再进入(STAR)是 CTO 经皮冠状动脉介入治疗(PCI)的第一种对比调制技术。在这种技术中,为了实现血管的水力再通,会强力注射大量对比剂(3-4 毫升)。这种方法会导致广泛的血管损伤和不可预测的真腔再进入,进而导致随访中的再狭窄率很高。在随后的迭代中,称为“微通道技术”,会向斑块内轻轻注射较小剂量的对比剂(1 毫升),通过软化和募集松散组织来改变其顺应性,从而在阻力最小的路径上用聚合物护套导丝促进随后的真正真腔穿越。微通道技术后来演变成目前称为“Carlino 技术”,其中向闭塞部位轻轻注射最小量的对比剂(<0.5 毫升),目的是改变斑块顺应性,以促进导丝和微导管通过纤维钙化斑块的推进。Carlino 技术现在被广泛用于允许“杂交手术者”通过高成功率和低并发症发生率来处理难以穿越的闭塞。本文的目的是提供 CTO PCI 中使用对比调制的历史背景、其病理生理基础,以及如何和何时进行这些操作的技术建议。